Technology and innovation

KYOCERA is committed to providing innovative products that help surgeons meet demanding patient needs.  By combining advanced materials and innovative design features with tried-and-true design principals, Renovis aims to enhance device performance and longevity. … [read more]

Tesera SA Stand-Alone ALIF Cage System

Is a porous titanium Stand-alone Anterior Cage designed to be part of the fusion, rather than merely a vessel for it.

Tesera SA Stand-Alone ALIF Cage System Tesera SA Stand-Alone ALIF Cage System

Tesera Trabecular Technology

Designed and built to promote bone in-growth and long-term stability.

Tesera Trabecular Technology Tesera Trabecular Technology

KYOCERA E-MAX Highly Crosslinked Polyethylene

Vitamin E blended for protection against oxidation ...

KYOCERA E-MAX Highly Crosslinked Polyethylene KYOCERA E-MAX Highly Crosslinked Polyethylene

Tesera SC Stand-Alone Cervical Interbody System

Combines advanced material science and revolutionary manufacturing process into a powerful ...

Tesera SC Stand-Alone Cervical Interbody System Tesera SC Stand-Alone Cervical Interbody System
Renovis Hip Product Group Renovis Knee Product Group Renovis Spine Product Group Renovis Trauma Product Group

Technology Spotlight

Tesera Trabecular Technology information.

Press Release

KYOCERA to Purchase Major Assets of U.S.-based Renovis Surgical Technologies, Inc.

-- Press Release -- January 16, 2019 - Kyocera Corporation (President: Hideo Tanimoto) today announced that its U.S. headquarters, Kyocera International, Inc., has finalized an agreement with Renovis Surgical Technologies, Inc. (herein “Renovis”), a U.S.-based orthopedic and spinal medical device manufacturer and developer, to purchase the major assets of Renovis’ business operations relating to artificial joint and spinal products.  The assets will be transferred into a new … [read more]


Distributor Inquiry